ATH 0.00% 0.4¢ alterity therapeutics limited

There are sure multiple good signs. You may not know, but in...

  1. 5,883 Posts.
    lightbulb Created with Sketch. 150
    There are sure multiple good signs. You may not know, but in their reach2HD trial the small sample(4 patients) they checked for brain atrophy over the trial showed the chelator they were using did slow brain atrophy. That was not an endpoint, and so small that nobody took much notice. There were some stat sig improvement on an executive function endpoint of Trial Making Test B. That was the more difficult test between A&B. That drug PBT2 was a zinc chelator, but also attracted other metals including iron.I am not going to argue the merits of Reach2HD, but just want to point out that there was a reduction in brain atrophy seen there, which is now more interesting.
    Executive function is the ability to think fast, eg champion soccer players have very high scores in executive function.
 
watchlist Created with Sketch. Add ATH (ASX) to my watchlist
(20min delay)
Last
0.4¢
Change
0.000(0.00%)
Mkt cap ! $21.28M
Open High Low Value Volume
0.4¢ 0.4¢ 0.4¢ $203.0K 45.14M

Buyers (Bids)

No. Vol. Price($)
104 103311567 0.4¢
 

Sellers (Offers)

Price($) Vol. No.
0.5¢ 31829254 17
View Market Depth
Last trade - 10.53am 30/07/2024 (20 minute delay) ?
ATH (ASX) Chart
arrow-down-2 Created with Sketch. arrow-down-2 Created with Sketch.